Welcome
Support Centre
21 November 2008 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
UKCTG
mental health register
archived registers
all registers
tips on searching
 
Registration
submit trials
 
Information
about mRCT
mRCT FAQs
data items
memorandum
contributors

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
A comparative study of the therapeutic effects of continuous and pulsed laser light on wound healing rates.
Source of recordUK Clinical Trials Gateway
ISRCTNISRCTN80835416
Date ISRCTN assigned30/09/2005
Local reference number(s)N0050058361
Public titleA comparative study of the therapeutic effects of continuous and pulsed laser light on wound healing rates.
Scientific title
AcronymN/A
Disease/condition/study domainInjury, Occupational Diseases, Poisoning: Wound healing
Study hypothesisThe study will investigate whether the effect of pulsed infra-red (IR) laser illumination of wounds can be distinguished from placebo therapy and continuous laser IR illumination and if the responses to pulsed laser therapy correlate with the responses to frequencies used in an earlier study of pulsed electromagnetic fields.
Design/methodologyRandomised controlled trial
Research ethics reviewNot provided at time of registration
Countries of trialUnited Kingdom
Participants - inclusion criteriaNot provided at time of registration
Participants - exclusion criteriaNot provided at time of registration
Patient information material
Anticipated start date06/07/1999
Anticipated end date31/07/2003
Status of trialCompleted
Target number of participants80 minimum in four groups each of 20 subjects
InterventionsThe study will be double-blinded. 80 minimum in four groups each of 20 subjects. A will be the control group, receiving no IR therapy; B will receive IR laser therapy pulsed at 292 Hz; C will receive IR laser therapy pulsed at 700 Hz; D will receive continuous IR laser illumination.

Each subject will be assessed on recruitment to the study and given a treatment session twice per week for four weeks. This will be followed by a 4-week observation period ending with the final assessment. After the initial assessment, subjects will be assessed at the ends of weeks 1 - 4 and 8 with a follow-up observation at the end of week 13. Patients' subjective comments will be sought throughout.
Primary outcome measure(s)The study will test the 'null hypotheses' that there are no significant differences between the control group and any other group at the 95% confidence level.
Secondary outcome measure(s)Not provided at time of registration
Sources of fundingBradford Teaching Hospitals NHS Foundation Trust
Sponsor nameRecord Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)
Sponsor detailsThe Department of Health, Richmond House, 79 Whitehall
London
United Kingdom
SW1A 2NL
Sponsor telephone+44 (0)20 7307 2622
Sponsor emaildhmail@doh.gsi.org.uk
Sponsor websitehttp://www.dh.gov.uk/Home/fs/en
Contact nameProf Peter Vowden
Contact detailsDepartment of Vascular Surgery
Bradford Royal Infirmary
Duckworth Lane

Bradford
United Kingdom
BD9 6RJ
Contact telephone+44 (0)1274 364466
Contact fax+44 (0)1274 364807
Contact emailpeter.vowden@bradfordhospitals.nhs.uk
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN80835416
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol Top studies in medical research Submit to Trials journal
terms & conditions | privacy statement | © Current Controlled Trials Ltd


BioMed Central